In a research report released Friday, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of Juno Therapeutics Inc (NASDAQ:JUNO), while slashing …
Maxim analyst Jason McCarthy comments on Mast Therapeutics Inc (NYSEMKT:MSTX) ahead of EPIC study data for the investigation of Sickle Cell Disease (SCD), …
In a research report released today, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of Juno Therapeutics (NASDAQ:JUNO), with a price target …
In a research note published Tuesday, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of Mast Therapeutics Inc (NYSEMKT:MSTX), with a price target …
Maxim analyst Jason McCarthy weighed in today with a few insights on Inovio Pharmaceuticals Inc (NASDAQ:INO), following the news that the company’s Zika vaccine candidate, GLS-5700, …
Maxim’s healthcare analyst Jason McCarthy weighed in today on cancer-drug maker Juno Therapeutics Inc (NASDAQ:JUNO) and cancer-vaccine maker Inovio Pharmaceuticals Inc (NASDAQ:INO). The analyst reflects on Juno’s opportunity in …
In a research note issued Friday, Maxim analyst Jason McCarthy reiterated a Hold rating on shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), after the …
Maxim’s healthcare analyst Jason McCarthy weighed in today with an optimistic view on bluebird bio Inc (NASDAQ:BLUE), after spending an evening with bluebird management and clients, …
In a research report published today, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of Galena Biopharma Inc (NASDAQ:GALE) with a $7 price …
Maxim analyst Jason McCarthy came out with a brief commentary on Inovio Pharmaceuticals Inc (NASDAQ:INO), after the company announced yesterday that the US Defense Advanced Research Projects Agency (DARPA) has …
